Skip to main content

Table 2 Clinical outcomes of DEB-TACE with CalliSpheres® beads

From: Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma

Variables

Value

Median operation time, min

70.0 (52.5, 101.0)

Median inpatient duration, days

10.0 (9.0, 15.0)

Median cost, IQR, ×104 RMB

7.1 (4.8–8.6)

The embolized arteries

 

The inferior thyroid artery

4 (19.0)

The bronchial artery

9 (42.9)

The proper esophageal artery

5 (23.8)

The intercostal artery

3 (14.3)

The left gastric artery

6 (28.6)

Complications, n (%)

 

Chest pain

3 (14.3)

Nausea or vomiting

2 (9.5)

Other treatments, n (%)

 

Superior vena cava stenting

1 (4.8)

Esophagus stenting

8 (38.1)

Airway stenting

6 (28.6)

125I seeds implantation

1 (4.8)